A detailed history of Manning & Napier Group, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Manning & Napier Group, LLC holds 258,118 shares of BSX stock, worth $23.3 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
258,118
Previous 299,575 13.84%
Holding current value
$23.3 Million
Previous $17.3 Million 2.07%
% of portfolio
0.2%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$57.6 - $68.62 $2.39 Million - $2.84 Million
-41,457 Reduced 13.84%
258,118 $17.7 Million
Q4 2023

Jan 19, 2024

SELL
$48.64 - $57.81 $62,113 - $73,823
-1,277 Reduced 0.42%
299,575 $17.3 Million
Q3 2023

Oct 20, 2023

SELL
$50.19 - $54.68 $8.13 Million - $8.86 Million
-162,021 Reduced 35.0%
300,852 $15.9 Million
Q2 2023

Jul 26, 2023

SELL
$49.72 - $54.64 $264,808 - $291,012
-5,326 Reduced 1.14%
462,873 $25 Million
Q1 2023

Apr 17, 2023

BUY
$45.09 - $50.03 $4.6 Million - $5.1 Million
102,028 Added 27.86%
468,199 $23.4 Million
Q4 2022

Jan 26, 2023

SELL
$39.56 - $47.22 $1.57 Million - $1.87 Million
-39,647 Reduced 9.77%
366,171 $0
Q3 2022

Oct 18, 2022

SELL
$36.71 - $109.66 $21,255 - $63,493
-579 Reduced 0.14%
405,818 $15.7 Million
Q2 2022

Jul 12, 2022

SELL
$35.24 - $47.1 $887,554 - $1.19 Million
-25,186 Reduced 5.84%
406,397 $15.1 Million
Q1 2022

Apr 19, 2022

SELL
$40.9 - $45.1 $490,800 - $541,200
-12,000 Reduced 2.71%
431,583 $19.1 Million
Q4 2021

Jan 27, 2022

SELL
$38.07 - $44.87 $33,501 - $39,485
-880 Reduced 0.2%
443,583 $18.8 Million
Q3 2021

Oct 14, 2021

SELL
$41.23 - $45.88 $90,912 - $101,165
-2,205 Reduced 0.49%
444,463 $19.3 Million
Q2 2021

Jul 19, 2021

SELL
$38.58 - $44.24 $537,457 - $616,307
-13,931 Reduced 3.02%
446,668 $19.1 Million
Q1 2021

Apr 28, 2021

BUY
$35.27 - $39.67 $1.12 Million - $1.26 Million
31,853 Added 7.43%
460,599 $17.8 Million
Q4 2020

Jan 20, 2021

BUY
$33.15 - $41.97 $1.49 Million - $1.88 Million
44,862 Added 11.69%
428,746 $15.4 Million
Q3 2020

Oct 29, 2020

SELL
$34.44 - $42.23 $194,276 - $238,219
-5,641 Reduced 1.45%
383,884 $14.7 Million
Q2 2020

Jul 10, 2020

BUY
$30.19 - $39.11 $463,990 - $601,081
15,369 Added 4.11%
389,525 $13.7 Million
Q1 2020

Apr 13, 2020

SELL
$25.83 - $45.71 $3.13 Million - $5.54 Million
-121,225 Reduced 24.47%
374,156 $12.2 Million
Q4 2019

Jan 10, 2020

SELL
$37.87 - $45.37 $1.52 Million - $1.82 Million
-40,095 Reduced 7.49%
495,381 $22.4 Million
Q3 2019

Oct 10, 2019

SELL
$40.31 - $43.45 $2.84 Million - $3.06 Million
-70,410 Reduced 11.62%
535,476 $21.8 Million
Q2 2019

Jul 24, 2019

BUY
$34.91 - $42.98 $21.2 Million - $26 Million
605,886 New
605,886 $26 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Manning & Napier Group, LLC Portfolio

Follow Manning & Napier Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manning & Napier Group, LLC with notifications on news.